Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $5.56 million. The enterprise value is -$3.10 million.
Important Dates
The next estimated earnings date is Monday, May 19, 2025, after market close.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 3.64 million shares outstanding. The number of shares has increased by 5,371.73% in one year.
| Current Share Class | 3.64M |
| Shares Outstanding | 3.64M |
| Shares Change (YoY) | +5,371.73% |
| Shares Change (QoQ) | +69.70% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 9.34% |
| Float | 3.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.07 |
| PS Ratio | 0.03 |
| Forward PS | n/a |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.11 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -662.43 |
Financial Efficiency
Return on equity (ROE) is -22.97% and return on invested capital (ROIC) is -15.69%.
| Return on Equity (ROE) | -22.97% |
| Return on Assets (ROA) | -12.55% |
| Return on Invested Capital (ROIC) | -15.69% |
| Return on Capital Employed (ROCE) | -23.97% |
| Revenue Per Employee | $670,659 |
| Profits Per Employee | -$98,733 |
| Employee Count | 52 |
| Asset Turnover | 1.20 |
| Inventory Turnover | 2.85 |
Taxes
| Income Tax | -234,858 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.68% in the last 52 weeks. The beta is 0.38, so SBFM's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -93.68% |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 44.81 |
| Average Volume (20 Days) | 4,333,414 |
Short Selling Information
The latest short interest is 141,279, so 3.89% of the outstanding shares have been sold short.
| Short Interest | 141,279 |
| Short Previous Month | 113,084 |
| Short % of Shares Out | 3.89% |
| Short % of Float | 4.23% |
| Short Ratio (days to cover) | 4.35 |
Income Statement
In the last 12 months, SBFM had revenue of $34.87 million and -$5.13 million in losses. Loss per share was -$7.32.
| Revenue | 34.87M |
| Gross Profit | 10.67M |
| Operating Income | -5.81M |
| Pretax Income | -3.72M |
| Net Income | -5.13M |
| EBITDA | -5.59M |
| EBIT | -5.81M |
| Loss Per Share | -$7.32 |
Full Income StatementBalance Sheet
The company has $9.69 million in cash and $952,480 in debt, giving a net cash position of $8.73 million or $2.40 per share.
| Cash & Cash Equivalents | 9.69M |
| Total Debt | 952,480 |
| Net Cash | 8.73M |
| Net Cash Per Share | $2.40 |
| Equity (Book Value) | 23.50M |
| Book Value Per Share | 9.10 |
| Working Capital | 19.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.53 million and capital expenditures -$1.66 million, giving a free cash flow of -$14.19 million.
| Operating Cash Flow | -12.53M |
| Capital Expenditures | -1.66M |
| Free Cash Flow | -14.19M |
| FCF Per Share | -$3.90 |
Full Cash Flow StatementMargins
Gross margin is 30.60%, with operating and profit margins of -16.67% and -14.72%.
| Gross Margin | 30.60% |
| Operating Margin | -16.67% |
| Pretax Margin | -15.40% |
| Profit Margin | -14.72% |
| EBITDA Margin | -16.02% |
| EBIT Margin | -16.67% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5,371.73% |
| Shareholder Yield | -5,371.73% |
| Earnings Yield | -91.10% |
| FCF Yield | -251.76% |
Analyst Forecast
The average price target for SBFM is $15.00, which is 880.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 880.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 8, 2024. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Aug 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
SBFM has an Altman Z-Score of -1.41 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.41 |
| Piotroski F-Score | 1 |